May 27, 2026 a 06:00 pm
EW: Fundamental Ratio Analysis - Edwards Lifesciences Corporation
Edwards Lifesciences Corporation, with its innovative products for structural heart disease and critical care monitoring, presents a compelling investment case. The company has shown consistent growth in its sector with promising future prospects. Investors may find value in its pioneering technologies and stable performance metrics.
Fundamental Rating
The fundamental analysis reveals a stable financial standing with room for improvement in valuation metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
Comparing past and present scores provides insight into company performance over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | 3 | 3 | 4 | 5 | 3 | 1 | 2 |
| Previous Record | 0 | 3 | 4 | 5 | 3 | 1 | 2 |
Analysts' Price Targets
Analysts provide a robust outlook with a moderate degree of confidence in price targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| $110 | $85 | $95 | $97.08 |
Analysts' Sentiment
The stock has received significant attention from analysts, with a majority having a positive outlook.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 32 | |
| Hold | 16 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Edwards Lifesciences Corporation offers a mixture of stable and promising growth prospects. While certain valuation metrics suggest a need for improved financial performance, its consistent performance in critical care and innovative heart disease solutions inspire confidence. The analysts' consensus supports a buy recommendation, reinforced by robust product offerings and strong market presence. However, investors should remain mindful of potential market fluctuations and industry challenges in healthcare.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years